Verrica Pharmaceuticals (VRCA)

• Market cap: $128M
• 1 day: -1.23%
• 5 days: -5.42%
• 1 month: -1.11%
• 3 months: 81.45%
• 6 months: -6.96%
• Year to date: -3.37%
• 1 year: 14.57%
• 5 years: -93.38%
• 10 years: -95.42%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71